TOL101

Results: 1



#Item
1Cutaneous T-cell lymphoma / Alemtuzumab / Lenalidomide / Neuroblastoma / TOL101 / Medicine / Lymphoma / Immunosuppressants

Fiscal Year 2012 OOPD New Awards The Office of Orphan Products Development (OOPD) is pleased to announce the new recipients of the Orphan Products Grants Program Awards for Fiscal year[removed]The recipients are as follows

Add to Reading List

Source URL: www.fda.gov

Language: English
UPDATE